Patent details

EP3552619 Title: FACTOR IX POLYPEPTIDES AND METHODS OF USE THEREOF

Basic Information

Publication number:
EP3552619
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP191560747
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FACTOR IX POLYPEPTIDES AND METHODS OF USE THEREOF
French Title of Invention:
POLYPEPTIDES DU FACTEUR IX ET LEURS PROCÉDÉS D'UTILISATION
German Title of Invention:
FAKTOR-IX-POLYPEPTIDE UND VERFAHREN ZUR VERWENDUNG DAVON
SPC Number:

Dates

Filing date:
11/07/2011
Grant date:
30/07/2025
EP Publication Date:
16/10/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/07/2025
EP B1 Publication Date:
30/07/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
11/07/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/07/2025
 
 

Name:
Bioverativ Therapeutics Inc.
Address:
225 Second Avenue, Waltham MA 02451, United States (US)

Inventor

1

Name:
PIERCE, Glenn
Address:
United States (US)

2

Name:
JIANG, Haiyan
Address:
United States (US)

3

Name:
TRUEX, Samantha
Address:
United States (US)

4

Name:
PETERS, Robert, T.
Address:
United States (US)

Priority

1

Priority Number:
36306410 P
Priority Date:
09/07/2010
Priority Country:
United States (US)

2

Priority Number:
201061424555 P
Priority Date:
17/12/2010
Priority Country:
United States (US)

3

Priority Number:
201161430819 P
Priority Date:
07/01/2011
Priority Country:
United States (US)

4

Priority Number:
201161438572 P
Priority Date:
01/02/2011
Priority Country:
United States (US)

5

Priority Number:
201161442079 P
Priority Date:
11/02/2011
Priority Country:
United States (US)

6

Priority Number:
201161470951 P
Priority Date:
01/04/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/38; A61K 38/36; A61K 39/395; A61P 7/04; C12N 9/64; A61K 47/64; A61K 38/48; C12N 9/96;

Publication

European Patent Bulletin

1

Issue number:
202531
Publication date:
30/07/2025
Description:
Grant (B1)

2

Issue number:
202534
Publication date:
20/08/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
16
Annual Fee Amount:
230 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages